Blocking both ICAM-1 and VCAM-1 did not reduce IGF1R or AKT activation in T-ALL cells more than blocking either adhesion molecule individually (Supplementary Fig. 6a, b), despite more significantly reducing T-ALL survival (Fig. 2a). This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.